Summit Therapeutics Inc Forecast and Target Price

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $37.4. This median of share price forecast represents a 64.4% upside from the latest price of $22.75 as on 16.05.25.

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 16.05.25, the difference is -34.04%